.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have developed a biomimetic scavenger called Nev-RA to enhance spinal cord injury repair. This innovative system targets cell-free DNA (cfDNA), which usually triggers severe neuroinflammation and neuronal death. By scavenging these pathogenic molecules, the treatment creates a more favorable environment for healing. Clinical management of spinal cord trauma often lacks effective ways to reverse the inhibitory microenvironment. Consequently, this new delivery system offers a promising therapeutic target for neurotrauma.
The Nev-RA system functions through a spatiotemporally controlled process. First, angiopep-2 peptides facilitate the penetration of the blood-spinal cord barrier. Once the carrier reaches the lesion site, reactive oxygen species (ROS) trigger the cleavage of the protective coating. This action exposes oligoarginines that effectively bind and neutralize cfDNA. Therefore, this prevents toll-like receptor 9 (TLR9) from initiating a damaging inflammatory cascade.
Furthermore, the extracellular vesicles (Nev) provide substantial neuroprotective benefits. They support the survival of impaired neurons and boost the intrinsic repair capacity of the spinal cord tissue. Additionally, the system addresses the dual barriers of a hostile microenvironment and insufficient natural regeneration. This paradigm represents a significant step forward in neurotrauma therapy. Scientists believe this biomimetic strategy could revolutionize how we treat acute spinal injuries in the future.
Cell-free DNA acts as a damage-associated molecular pattern (DAMP). It binds to TLR9 receptors, which induces chronic neuroinflammation and leads to the death of healthy neurons, thereby hindering recovery.
The system uses angiopep-2, a specific peptide that binds to LRP1 receptors on the barrier. This allows the therapeutic package to reach the lesion site efficiently from the bloodstream without invasive direct injections.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Scientists design a cfDNA scavenger that neutralizes inflammation and promotes neural repair after spinal cord injury by leveraging extracellular vesicles....
6 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
